Connection

Alessandro Bartoloni to Pyrimidines

Back to Details
This is a "connection" page, showing publications Alessandro Bartoloni has written about Pyrimidines.
Alessandro Bartoloni
Connection Strength
0.061
Pyrimidines
  1. Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib. Am J Hematol. 2021 11 01; 96(11):E408-E410.
    View in: PubMed
    Score: 0.032
  2. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.